Industry
The DGCCRF has announced that the use of the word “probiotic” can be allowed on the label of dietary supplements, as well as the health claim “contributes to the balance…
Fabio Grassi, Founder at MV BioTherapeutics SA, discussed how to understand the mechanisms of action for microbiome contributions to cancer therapeutic response in patients.
First patient to be administered Oncobax® AK, a live bacterial product based on a specific strain found in the gut microbiota, at Institut de Cancérologie Strasbourg Europe (ICANS) in Strasbourg,…
Felix Faupel, Chief Commercial Officer at Bacthera, discussed how the combination of the new Lonza Capsugel® Enprotect™ capsule and Bacthera services will accelerate time-to-human and time-to-market.
The OncobiotaLUNG assay is the first blood microbiome-driven liquid biopsy with proven effectiveness, including identifying cancer in its earliest stages
Gynecologist Franco Vicariotto and Virginia Franco, CEO and Co-Founder Yoni Solutions, discuss how personalized analysis and personalized therapy are within the reach of today's woman.
Funding round led by Shanghai Healthcare Capital. The financing round will enable Biomica to forge ahead, developing its pipeline of microbiome-based therapeutics.
Biopharma companies are currently developing Live Biotherapeutic Products. We discussed this topic with Morten Isaksen (BIO-ME).
Strategic investment in dynamic research field of skin microbiome to drive future of skin care.
Emily Hollister discussed how Diversigen demonstrates the rapidity of microbial gene expression changes potentially impacting host-microbiome interactions.
